Therapeutic Asset Ratings

141 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ibandronate Metastatic Cancer	Kelly Fitzgerald, MD	P3	B (62)
PREDNISONE TABLETS Metastatic Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P3	B (62)
Pyrotinib Metastatic Cancer	BeOne Medicines	P2	B (62)
Atezolizumab Metastatic Cancer	Genentech, Inc.	P2/3	B (62)
Bms-907351 Metastatic Cancer	Rana McKay, MD	P3	B (61)
MITOMYCIN C Metastatic Cancer	City of Hope Medical Center	P3	B (60)
PANITUMUMAB Metastatic Cancer	National Cancer Institute (NCI)	P2	B (60)
MIDAZOLAM Metastatic Cancer	Cogent Biosciences, Inc.	P3	B (59)
Fludarabine Metastatic Cancer	Beijing Biotech	P2	B (59)
su011248 Metastatic Cancer	Cogent Biosciences, Inc.	P3	B (58)
Adagrasib Metastatic Cancer	Mirati Therapeutics Inc.	P2	B (58)
Crizotinib Metastatic Cancer	M.D. Anderson Cancer Center	P2	B (58)
Osimertinib Metastatic Cancer	Shanghai Chest Hospital	P2	B (58)
Namenda Metastatic Cancer	NRG Oncology	P3	B (57)
TRASTUZUMAB Metastatic Cancer	Seoul National University Bundang Hospital	P1/2	B (57)
Abiraterone Acetate Metastatic Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P2	CCC (55)
Darolutamide Metastatic Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P2	CCC (55)
Enzalutamide Metastatic Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P2	CCC (55)
Givastomig Metastatic Cancer	I-Mab Biopharma US Limited	P2	CCC (55)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER Metastatic Cancer	Xiuning Le	P2	CCC (55)
Nab-Sirolimus Metastatic Cancer	Mirati Therapeutics Inc.	P2	CCC (55)
Niraparib Metastatic Cancer	Tempus AI	P2	CCC (55)
Bezuclastinib Metastatic Cancer	Cogent Biosciences, Inc.	P3	CCC (54)
Alnodesertib Metastatic Cancer	Artios Pharma Ltd	P2	CCC (54)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE Metastatic Cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P2	CCC (54)

Showing 26 to 50 of 141 assets

PreviousPage 2 of 6Next